MedPath

Rozerem

Approved
Approval ID

7a51d289-2013-4d37-adf2-91ea49df7932

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 20, 2010

Manufacturers
FDA

Physicians Total Care, Inc.

DUNS: 194123980

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ramelteon

PRODUCT DETAILS

NDC Product Code54868-5649
Application NumberNDA021782
Marketing CategoryC73594
Route of AdministrationORAL
Effective DateJanuary 20, 2010
Generic Nameramelteon

INGREDIENTS (12)

FERROSOFERRIC OXIDEInactive
Code: XM0M87F357
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
HYDROXYPROPYL CELLULOSEInactive
Code: RFW2ET671P
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
HYPROMELLOSEInactive
Code: 3NXW29V3WO
Classification: IACT
COPOVIDONEInactive
Code: D9C330MD8B
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT
POLYETHYLENE GLYCOL 8000Inactive
Code: Q662QK8M3B
Classification: IACT
SHELLACInactive
Code: 46N107B71O
Classification: IACT
RAMELTEONActive
Quantity: 8 mg in 1 1
Code: 901AS54I69
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Rozerem - FDA Drug Approval Details